ELAN - Elanco Animal Health - Stock & Dividends

Elanco Animal Health is a leading animal health company that develops, manufactures, and markets a wide range of innovative products for pets and farm animals. Their pet health portfolio includes disease prevention products, such as parasiticides and vaccines, that protect pets from parasites like worms, fleas, and ticks under well-known brands like Seresto, Advantage, Advantix, and Advocate.

In addition, Elanco offers a variety of pet health therapeutics to treat conditions like pain, osteoarthritis, ear infections, cardiovascular disease, and dermatology issues in dogs and cats, marketed under brands like Galliprant and Claro. These products are designed to improve the health and well-being of companion animals.

For the livestock industry, Elanco provides a broad range of products, including vaccines, antibiotics, parasiticides, and nutritional health products like enzymes, probiotics, and prebiotics. These products are used in poultry and aquaculture production to promote healthy growth and prevent disease. The company also offers a range of products for ruminant and swine production, including vaccines, antibiotics, implants, and parasiticides, marketed under brands like Rumensin and Baytril.

Elanco's products are sold to a diverse customer base, including third-party distributors, veterinarians, and farm animal producers, such as beef and dairy farmers, as well as pork, poultry, and aquaculture operations. With a rich history dating back to 1954, Elanco Animal Health is headquartered in Greenfield, Indiana, and is committed to improving the health and well-being of animals around the world. For more information, visit their website at https://www.elanco.com.